7 WADA Prohibited List (S2)Growth hormone secretagogues including GHRH analogs and ghrelin / GHS-R1a agonists are prohibited at all times under class S2
Retatrutide asks whether triple receptor agonism can create a new efficacy ceiling
Granata A, Maccarrone R, Anzaldi M, Leonardi G, Pesce F, Amico F, et al (2022) GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: State of the art
"About the Trump, Eli Lilly, Novo Nordisk deals on GLP-1 prices." ncpa.org Axios
Injection sites must be shifted each week to avoid skin irritation between the abdomen, upper thigh, or the backs of the upper arms
GHK-Cu is present endogenously in blood, saliva, and urine, declining from approximately 200 ng/mL at age 20 to approximately 80 ng/mL by age 60